Near-fatal asthma in South Australia: Descriptive features and medication use

D. A. Campbell, C. G. Luke, G. McLennan, J. R. Coates, P. A. Frith, P. A. Gluyas, K. M. Latimer, A. J. Martin, R. E. Ruffin, Peter Mackinlay Yellowlees, D. M. Roder

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Background: Self-reported prior morbidity levels and medication use among survivors of a near-fatal asthma attack (NFA) were studied. Aims: To identify deficiencies in asthma management and opportunities for intervention. Methods: A hundred and twenty-seven consecutive patients aged 15 years or more presenting with a NFA to accident and emergency departments of teaching hospitals were interviewed. Results: High levels of morbidity due to asthma were reported. Most cases (79%) reported symptoms occurring at least weekly in the three months before their NFA. A mean of 20.8 days was reportedly lost from work, school or other usual daily activity in the 12 months before these events. Regular use of beta agonist as nebuliser solution was reported by 27% of cases, increasing to 34.5% in response to increased symptoms, while 41% reported use of nebulised beta agonist in response to the NFA event. Less than half of all cases (46%) reported using an inhaled corticosteroid on a regular basis. Oral corticosteroids were used by 33% of cases at times of increased symptoms in the preceding 12 months. However, only 7% of cases reported initiating or increasing oral corticosteroids at the time of the NFA. Conclusions: Despite high levels of prior asthma morbidity, regular preventive inhaled corticosteroid use was not widespread in this series of NFA asthmatics. By comparison, over-reliance on regular beta agonist medication was common. Oral corticosteroids were rarely commenced in response to the NFA.

Original languageEnglish (US)
Pages (from-to)356-362
Number of pages7
JournalAustralian and New Zealand Journal of Medicine
Volume26
Issue number3
StatePublished - 1996
Externally publishedYes

Fingerprint

South Australia
Asthma
Adrenal Cortex Hormones
Morbidity
Nebulizers and Vaporizers
Teaching Hospitals
Survivors
Hospital Emergency Service

Keywords

  • Asthma
  • medications
  • morbidity
  • mortality
  • near-fatal

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Campbell, D. A., Luke, C. G., McLennan, G., Coates, J. R., Frith, P. A., Gluyas, P. A., ... Roder, D. M. (1996). Near-fatal asthma in South Australia: Descriptive features and medication use. Australian and New Zealand Journal of Medicine, 26(3), 356-362.

Near-fatal asthma in South Australia : Descriptive features and medication use. / Campbell, D. A.; Luke, C. G.; McLennan, G.; Coates, J. R.; Frith, P. A.; Gluyas, P. A.; Latimer, K. M.; Martin, A. J.; Ruffin, R. E.; Yellowlees, Peter Mackinlay; Roder, D. M.

In: Australian and New Zealand Journal of Medicine, Vol. 26, No. 3, 1996, p. 356-362.

Research output: Contribution to journalArticle

Campbell, DA, Luke, CG, McLennan, G, Coates, JR, Frith, PA, Gluyas, PA, Latimer, KM, Martin, AJ, Ruffin, RE, Yellowlees, PM & Roder, DM 1996, 'Near-fatal asthma in South Australia: Descriptive features and medication use', Australian and New Zealand Journal of Medicine, vol. 26, no. 3, pp. 356-362.
Campbell DA, Luke CG, McLennan G, Coates JR, Frith PA, Gluyas PA et al. Near-fatal asthma in South Australia: Descriptive features and medication use. Australian and New Zealand Journal of Medicine. 1996;26(3):356-362.
Campbell, D. A. ; Luke, C. G. ; McLennan, G. ; Coates, J. R. ; Frith, P. A. ; Gluyas, P. A. ; Latimer, K. M. ; Martin, A. J. ; Ruffin, R. E. ; Yellowlees, Peter Mackinlay ; Roder, D. M. / Near-fatal asthma in South Australia : Descriptive features and medication use. In: Australian and New Zealand Journal of Medicine. 1996 ; Vol. 26, No. 3. pp. 356-362.
@article{87d4c4fbf69e470ba85b53bf0fdc3b7a,
title = "Near-fatal asthma in South Australia: Descriptive features and medication use",
abstract = "Background: Self-reported prior morbidity levels and medication use among survivors of a near-fatal asthma attack (NFA) were studied. Aims: To identify deficiencies in asthma management and opportunities for intervention. Methods: A hundred and twenty-seven consecutive patients aged 15 years or more presenting with a NFA to accident and emergency departments of teaching hospitals were interviewed. Results: High levels of morbidity due to asthma were reported. Most cases (79{\%}) reported symptoms occurring at least weekly in the three months before their NFA. A mean of 20.8 days was reportedly lost from work, school or other usual daily activity in the 12 months before these events. Regular use of beta agonist as nebuliser solution was reported by 27{\%} of cases, increasing to 34.5{\%} in response to increased symptoms, while 41{\%} reported use of nebulised beta agonist in response to the NFA event. Less than half of all cases (46{\%}) reported using an inhaled corticosteroid on a regular basis. Oral corticosteroids were used by 33{\%} of cases at times of increased symptoms in the preceding 12 months. However, only 7{\%} of cases reported initiating or increasing oral corticosteroids at the time of the NFA. Conclusions: Despite high levels of prior asthma morbidity, regular preventive inhaled corticosteroid use was not widespread in this series of NFA asthmatics. By comparison, over-reliance on regular beta agonist medication was common. Oral corticosteroids were rarely commenced in response to the NFA.",
keywords = "Asthma, medications, morbidity, mortality, near-fatal",
author = "Campbell, {D. A.} and Luke, {C. G.} and G. McLennan and Coates, {J. R.} and Frith, {P. A.} and Gluyas, {P. A.} and Latimer, {K. M.} and Martin, {A. J.} and Ruffin, {R. E.} and Yellowlees, {Peter Mackinlay} and Roder, {D. M.}",
year = "1996",
language = "English (US)",
volume = "26",
pages = "356--362",
journal = "Internal Medicine Journal",
issn = "1444-0903",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - Near-fatal asthma in South Australia

T2 - Descriptive features and medication use

AU - Campbell, D. A.

AU - Luke, C. G.

AU - McLennan, G.

AU - Coates, J. R.

AU - Frith, P. A.

AU - Gluyas, P. A.

AU - Latimer, K. M.

AU - Martin, A. J.

AU - Ruffin, R. E.

AU - Yellowlees, Peter Mackinlay

AU - Roder, D. M.

PY - 1996

Y1 - 1996

N2 - Background: Self-reported prior morbidity levels and medication use among survivors of a near-fatal asthma attack (NFA) were studied. Aims: To identify deficiencies in asthma management and opportunities for intervention. Methods: A hundred and twenty-seven consecutive patients aged 15 years or more presenting with a NFA to accident and emergency departments of teaching hospitals were interviewed. Results: High levels of morbidity due to asthma were reported. Most cases (79%) reported symptoms occurring at least weekly in the three months before their NFA. A mean of 20.8 days was reportedly lost from work, school or other usual daily activity in the 12 months before these events. Regular use of beta agonist as nebuliser solution was reported by 27% of cases, increasing to 34.5% in response to increased symptoms, while 41% reported use of nebulised beta agonist in response to the NFA event. Less than half of all cases (46%) reported using an inhaled corticosteroid on a regular basis. Oral corticosteroids were used by 33% of cases at times of increased symptoms in the preceding 12 months. However, only 7% of cases reported initiating or increasing oral corticosteroids at the time of the NFA. Conclusions: Despite high levels of prior asthma morbidity, regular preventive inhaled corticosteroid use was not widespread in this series of NFA asthmatics. By comparison, over-reliance on regular beta agonist medication was common. Oral corticosteroids were rarely commenced in response to the NFA.

AB - Background: Self-reported prior morbidity levels and medication use among survivors of a near-fatal asthma attack (NFA) were studied. Aims: To identify deficiencies in asthma management and opportunities for intervention. Methods: A hundred and twenty-seven consecutive patients aged 15 years or more presenting with a NFA to accident and emergency departments of teaching hospitals were interviewed. Results: High levels of morbidity due to asthma were reported. Most cases (79%) reported symptoms occurring at least weekly in the three months before their NFA. A mean of 20.8 days was reportedly lost from work, school or other usual daily activity in the 12 months before these events. Regular use of beta agonist as nebuliser solution was reported by 27% of cases, increasing to 34.5% in response to increased symptoms, while 41% reported use of nebulised beta agonist in response to the NFA event. Less than half of all cases (46%) reported using an inhaled corticosteroid on a regular basis. Oral corticosteroids were used by 33% of cases at times of increased symptoms in the preceding 12 months. However, only 7% of cases reported initiating or increasing oral corticosteroids at the time of the NFA. Conclusions: Despite high levels of prior asthma morbidity, regular preventive inhaled corticosteroid use was not widespread in this series of NFA asthmatics. By comparison, over-reliance on regular beta agonist medication was common. Oral corticosteroids were rarely commenced in response to the NFA.

KW - Asthma

KW - medications

KW - morbidity

KW - mortality

KW - near-fatal

UR - http://www.scopus.com/inward/record.url?scp=8944246798&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=8944246798&partnerID=8YFLogxK

M3 - Article

C2 - 8811208

AN - SCOPUS:8944246798

VL - 26

SP - 356

EP - 362

JO - Internal Medicine Journal

JF - Internal Medicine Journal

SN - 1444-0903

IS - 3

ER -